首页> 外文期刊>American Journal of Translational Research >Efficacy of nifedipine tablets plus aspirin in patients with gestational hypertension and the effect on coagulation function and hemorheology
【24h】

Efficacy of nifedipine tablets plus aspirin in patients with gestational hypertension and the effect on coagulation function and hemorheology

机译:硝苯地平片加阿司匹林在妊娠期高血压患者中的疗效以及对凝血功能和血液流变学的影响

获取原文
           

摘要

Objective: This study aimed to investigate the clinical efficacy of Nifedipine tablets plus Aspirin for hypertensive disorder complicating pregnancy and the effect on coagulation function and hemorheology. Methods: A retrospective analysis of the clinical data from 108 patients with gestational hypertension hospitalized between March 2016 and March 2017 was carried out. These patients were randomly assigned into a research group and a control group, with 54 patients in each group. Patients were treated with Aspirin in the control group, and the combination of Nifedipine tablets and Aspirin in the research group so as to compare the clinical efficacy and the effect on coagulation function and hemorheology after therapy. Albumin, total protein, 24-hour urinary protein and mean arterial pressure (MAP) were observed and compared between the two groups. Results: The overall effective rate of treatment in the research group was significantly higher than that in the control group (P 0.05). The prothrombin time (PT) and fibrinogen (FIB) levels were markedly superior to those before therapy in the research group (P 0.001), and the PT and FIB after treatment were remarkably better in the research group than in the control group (P 0.001). The levels of plasma viscosity (PV), low-shear whole blood viscosity (LBV), and high-shear whole blood viscosity (HBV) after therapy were markedly reduced than before therapy in the two groups (P 0.05), and the levels of PV, LBV, and HBV after therapy were significantly lower in the research group than those in the control group (P 0.05). Adverse reactions after therapy were reported at a significantly lower incidence in the research group than the control group (P 0.05). Adverse pregnancy outcomes were reported at a significantly lower incidence in the research group than in the control group (P 0.05). The research group significantly outperformed the control group on Albumin, total protein, 24-hour urinary protein and mean arterial pressure (P 0.05). Conclusion: Nifedipine tablets plus Aspirin for patients with gestational hypertension can effectively improve coagulation function and hemorheological parameters, with high safety.
机译:目的:本研究旨在探讨硝苯地平片剂加上阿司匹林对妊娠的高血压障碍的临床疗效及对凝血功能和血液流变学的影响。方法:对2016年3月至2017年3月间住院108例妊娠期高血压患者的临床资料的回顾性分析。将这些患者随机分配到研究组和对照组中,每组54例患者。患者在对照组中用阿司匹林治疗,以及硝苯地平片剂和阿司匹林在研究组中的组合,以比较临床疗效和治疗后凝血功能和血液流变的影响。在两组之间观察到白蛋白,总蛋白质,24小时尿蛋白和平均动脉压(MAP)。结果:研究组中的整体有效治疗率明显高于对照组(P <0.05)。凝血酶原时间(PT)和纤维蛋白原(FIB)水平明显优于研究组(P <0.001)之前的治疗前的那些,并且在研究组中的PT和FIB在研究组中比对照组显着更好( P <0.001)。血浆粘度(PV)的水平,低剪切全血粘度(LBV)和治疗后的高剪切整个血液粘度(HBV)显着降低,两组疗法在治疗前(P <0.05)和研究组在治疗后PV,LBV和HBV的水平显着低于对照组(P <0.05)。报告治疗后的不良反应,在研究组的发生率显着降低了比对照组(P <0.05)。在研究组的发病率下报告了不良妊娠结果而不是对照组(P <0.05)。研究组在白蛋白,总蛋白质,24小时尿蛋白和平均动脉压下的对照组显着优于对照组(P <0.05)。结论:Nifedipine片剂加上妊娠高血压患者的阿司匹林可有效改善凝血功能和血液流变学参数,具有高安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号